AtriCure
ATRC
ATRC
213 hedge funds and large institutions have $2.98B invested in AtriCure in 2021 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 69 increasing their positions, 84 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
2.6% less ownership
Funds ownership: 97.11% → 94.51% (-2.6%)
15% less capital invested
Capital invested by funds: $3.49B → $2.98B (-$507M)
18% less repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 84
Holders
213
Holding in Top 10
3
Calls
$1.87M
Puts
$1.51M
Top Buyers
| 1 | +$24.3M | |
| 2 | +$23.2M | |
| 3 | +$15.7M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$11.3M |
| 5 |
CA
CastleArk Alternatives
Chicago,
Illinois
|
+$11.2M |
Top Sellers
| 1 | -$46.9M | |
| 2 | -$26.2M | |
| 3 | -$25.3M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$11.9M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$11.1M |